Vertex Pharmaceuticals Ownership & Insider Activity

Vertex Pharmaceuticals Inc

VRTXNASDAQ

Trade with Public

$547.65

3.130.57%

近くで: Aug 31, 5:00 PM EST

$548.51

3.990.73%

プレマーケット: 6:51 AM EST

M&A: Crinetics Pharmaceuticals (CRNX) was acquired by Vertex Pharmaceuticals (VRTX) on Tuesday, September 1, 2026 for $10B paid in cash

概要ニュース業績予想イベント目標株価財務センチメント株主構成比較株式レポート

Vertex Pharmaceuticals Ownership & Insider Activity

Vertex Pharmaceuticals (VRTX) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 1.0% of shares outstanding. Institutional investors hold 89.9%. Over the past 90 days, insiders made 7 sales worth $5.4M.

Shares Outstanding

253.461M

Shares Float

224.425M

Insider Shares Owned

2.519M

Insider % Owned

1.0%

Institutional Shares Held

227.830M

Institutional % Held

89.9%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$5.4M total

Net Activity

Net Selling

Net Value (90d)

-$5.4M

Vertex Pharmaceuticals Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Jul 2, 2026	Ourania Tatsis	EVP, CHIEF REG. & QUALITY OFF.	SELL	1.500K	$524.99	$787K
Jul 2, 2026	Duncan McKechnie	EVP, CHIEF COMMERCIAL OFFICER	SELL	1.541K	$519.00	$800K
Jul 1, 2026	Joy Liu	EVP AND CHIEF LEGAL OFFICER	SELL	828.000	$502.71	$416K
Jun 26, 2026	Carmen Bozic	EVP AND CMO	SELL	596.000	$482.50	$288K
Jun 18, 2026	Carmen Bozic	EVP AND CMO	SELL	1.020K	$462.17	$471K
Jun 15, 2026	Carmen Bozic	EVP AND CMO	SELL	4.062K	$450.00	$1.8M
Jun 5, 2026	Carmen Bozic	EVP AND CMO	SELL	1.745K	$450.00	$785K
Jun 1, 2026	Joy Liu	EVP AND CHIEF LEGAL OFFICER	SELL	828.000	$439.91	$364K
May 29, 2026	Carmen Bozic	EVP AND CMO	SELL	1.974K	$450.00	$888K
May 15, 2026	Mark Bunnage	EVP, CHIEF SCIENTIFIC OFFICER	SELL	33.000	$453.45	$15K
May 15, 2026	Carmen Bozic	EVP AND CMO	SELL	1.354K	$453.45	$614K
May 12, 2026	Carmen Bozic	EVP AND CMO	SELL	6.988K	$450.00	$3.1M
May 1, 2026	Joy Liu	EVP AND CHIEF LEGAL OFFICER	SELL	1.104K	$425.02	$469K
May 1, 2026	Sangeeta Bhatia	DIRECTOR	GRANT	625.000	$423.73	$135K
Apr 1, 2026	Joy Liu	EVP AND CHIEF LEGAL OFFICER	SELL	978.000	$449.17	$439K
Mar 27, 2026	Carmen Bozic	EVP AND CMO	SELL	2.329K	$450.95	$1.1M
Mar 13, 2026	Carmen Bozic	EVP AND CMO	SELL	2.329K	$481.79	$1.1M
Mar 11, 2026	Duncan McKechnie	EVP, CHIEF COMMERCIAL OFFICER	SELL	2.633K	$498.42	$1.3M
Mar 4, 2026	Duncan McKechnie	EVP, CHIEF COMMERCIAL OFFICER	SELL	2.437K	$475.30	$1.2M

More with Benzinga EdgeGet Access

Congressional Trading Activity

Date	Member	Party	Chamber	Action	Amount
Mar 27, 2026	Alan Armstrong	R	Senate	P	$1,001 - $15,000
Jan 29, 2026	David Taylor	R	House	S	$1,001 - $15,000
Aug 7, 2025	David Taylor	R	House	P	$1,001 - $15,000
Jun 11, 2025	Lisa McClain	R	House	S	$1,001 - $15,000
Jun 10, 2025	Lisa McClain	R	House	S (Partial)	$1,001 - $15,000
May 12, 2025	Jefferson Shreve	R	House	S	$15,001 - $50,000
Mar 20, 2025	Byron Donalds	R	House	S	$1,001 - $15,000
Mar 20, 2025	Byron Donalds	R	House	S	$1,001 - $15,000
Mar 13, 2025	Jefferson Shreve	R	House	P	$15,001 - $50,000
Feb 24, 2025	Jefferson Shreve	R	House	P	$15,001 - $50,000
Dec 11, 2024	Lisa McClain	R	House	P	$1,001 - $15,000
Oct 23, 2024	Julia Letlow	R	House	P	$1,001 - $15,000
May 3, 2024	Tommy Tuberville	R	Senate	S	$1,001 - $15,000
May 3, 2024	Tommy Tuberville	R	Senate	S	$1,001 - $15,000
Oct 24, 2023	Greg Stanton	D	House	S	$1,001 - $15,000
Sep 26, 2023	Greg Stanton	D	House	P	$1,001 - $15,000

More with Benzinga EdgeGet Access

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals Ownership & Insider Activity

Vertex Pharmaceuticals Insider Transactions (Last 6 Months)

Congressional Trading Activity

People Also Watch

ニュース

パートナーシップ

ベンジンガ・グローバル

People Also Watch